Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin combinations in advanced osteosarcoma
NCT02099396Phase 3Unknown
- Sponsor
- China Association of Osteosarcoma Chemotherapy
- Start
- Apr 2014
- Primary completion
- Jun 2016
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of lobaplatin in osteosarcoma (OS), sponsored by China Association of Osteosarcoma Chemotherapy. Status: unknown.
02
Drugs
lobaplatin
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT02099396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099396.